Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Hyperencapsulated mucoid pneumococcal isolates from patients with cystic fibrosis have increased biofilm density and persistence in vivo.

Dennis EA, Coats MT, Griffin S, Pang B, Briles DE, Crain MJ, Swords WE.

Pathog Dis. 2018 Oct 1;76(7). doi: 10.1093/femspd/fty073.

PMID:
30265307
2.

Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: a retrospective study.

Stoll ML, Grubbs JA, Beukelman T, Mannion ML, Jester TW, Cron RQ, Crain MJ.

Pediatr Rheumatol Online J. 2017 Nov 9;15(1):79. doi: 10.1186/s12969-017-0207-8.

3.

Growth at 2 Years of Age in HIV-exposed Uninfected Children in the United States by Trimester of Maternal Antiretroviral Initiation.

Jacobson DL, Patel K, Williams PL, Geffner ME, Siberry GK, DiMeglio LA, Crain MJ, Mirza A, Chen JS, McFarland E, Kacanek D, Silio M, Rich K, Borkowsky W, Van Dyke RB, Miller TL; Pediatric HIVAIDS Cohort Study.

Pediatr Infect Dis J. 2017 Feb;36(2):189-197. doi: 10.1097/INF.0000000000001387.

4.

Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia.

Melvin AJ, Montepiedra G, Aaron L, Meyer WA 3rd, Spiegel HM, Borkowsky W, Abzug MJ, Best BM, Crain MJ, Borum PR, Graham B, Anthony P, Shin K, Siberry GK; P1063 Study Team.

Pediatr Infect Dis J. 2017 Jan;36(1):53-60.

5.

Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.

Williams PL, Hazra R, Van Dyke RB, Yildirim C, Crain MJ, Seage GR 3rd, Civitello L, Ellis A, Butler L, Rich K; Pediatric HIV/AIDS Cohort Study.

AIDS. 2016 Jan 2;30(1):133-44. doi: 10.1097/QAD.0000000000000916.

6.

The Effects of CFTR and Mucoid Phenotype on Susceptibility and Innate Immune Responses in a Mouse Model of Pneumococcal Lung Disease.

Dennis EA, Coats MT, Griffin SE, Hale JY, Novak L, Briles DE, Crain MJ.

PLoS One. 2015 Oct 15;10(10):e0140335. doi: 10.1371/journal.pone.0140335. eCollection 2015.

7.

Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.

Williams PL, Crain MJ, Yildirim C, Hazra R, Van Dyke RB, Rich K, Read JS, Stuard E, Rathore M, Mendez HA, Watts DH; Pediatric HIV/AIDS Cohort Study.

JAMA Pediatr. 2015 Jan;169(1):48-55. doi: 10.1001/jamapediatrics.2014.1889.

8.

Invasive and noninvasive Streptococcus pneumoniae capsule and surface protein diversity following the use of a conjugate vaccine.

Croney CM, Nahm MH, Juhn SK, Briles DE, Crain MJ.

Clin Vaccine Immunol. 2013 Nov;20(11):1711-8. doi: 10.1128/CVI.00381-13. Epub 2013 Sep 4.

9.
10.

PspA family distribution, unlike capsular serotype, remains unaltered following introduction of the heptavalent pneumococcal conjugate vaccine.

Croney CM, Coats MT, Nahm MH, Briles DE, Crain MJ.

Clin Vaccine Immunol. 2012 Jun;19(6):891-6. doi: 10.1128/CVI.05671-11. Epub 2012 Apr 25.

11.

Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications.

Crain MJ, Williams PL, Griner R, Tassiopoulos K, Read JS, Mofenson LM, Rich KC; Pediatric HIVAIDS Cohort Study.

Pediatr Infect Dis J. 2011 Dec;30(12):1069-74. doi: 10.1097/INF.0b013e318234c886.

12.

Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV.

Crain MJ, Chernoff MC, Oleske JM, Brogly SB, Malee KM, Borum PR, Meyer WA 3rd, Mitchell WG, Moye JH, Ford-Chatterton HM, Van Dyke RB, Seage Iii GR.

J Infect Dis. 2010 Jul 15;202(2):291-301. doi: 10.1086/653497.

13.

In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.

Brogly SB, Ylitalo N, Mofenson LM, Oleske J, Van Dyke R, Crain MJ, Abzug MJ, Brady M, Jean-Philippe P, Hughes MD, Seage GR 3rd.

AIDS. 2007 May 11;21(8):929-38.

PMID:
17457086
14.

Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.

Johnson CN, Benjamin Jr WH Jr, Moser SA, Hollingshead SK, Zheng X, Crain MJ, Nahm MH, Waites KB.

J Clin Microbiol. 2003 Jun;41(6):2458-64.

15.

Evolution and virulence of serogroup 6 pneumococci on a global scale.

Robinson DA, Briles DE, Crain MJ, Hollingshead SK.

J Bacteriol. 2002 Nov;184(22):6367-75.

16.

Clones of Streptococcus pneumoniae isolated from nasopharyngeal carriage and invasive disease in young children in central Tennessee.

Robinson DA, Edwards KM, Waites KB, Briles DE, Crain MJ, Hollingshead SK.

J Infect Dis. 2001 May 15;183(10):1501-7. Epub 2001 Apr 17. Erratum in: J Infect Dis 2001 Nov 1;184(9):1228.

PMID:
11319686
17.

Human antibodies to pneumococcal surface protein A in health and disease.

Virolainen A, Russell W, Crain MJ, Rapola S, Käyhty H, Briles DE.

Pediatr Infect Dis J. 2000 Feb;19(2):134-8.

PMID:
10694000
18.

Characterization of a multidrug-resistant clone of invasive Streptococcus pneumoniae serotype 6B in Alaska by using pulsed-field gel electrophoresis and PspA serotyping.

Rudolph KM, Crain MJ, Parkinson AJ, Roberts MC.

J Infect Dis. 1999 Nov;180(5):1577-83. Erratum in: J Infect Dis 2000 Feb;181(2):814.

PMID:
10515818
19.

Molecular characterization of a globally distributed lineage of serotype 12F Streptococcus pneumoniae causing invasive disease.

Robinson DA, Turner JS, Facklam RR, Parkinson AJ, Breiman RF, Gratten M, Steinhoff MC, Hollingshead SK, Briles DE, Crain MJ.

J Infect Dis. 1999 Feb;179(2):414-22.

PMID:
9878026
20.

Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).

Briles DE, Tart RC, Swiatlo E, Dillard JP, Smith P, Benton KA, Ralph BA, Brooks-Walter A, Crain MJ, Hollingshead SK, McDaniel LS.

Clin Microbiol Rev. 1998 Oct;11(4):645-57. Review.

21.

The IS1167 insertion sequence is a phylogenetically informative marker among isolates of serotype 6B Streptococcus pneumoniae.

Robinson DA, Hollingshead SK, Musser JM, Parkinson AJ, Briles DE, Crain MJ.

J Mol Evol. 1998 Aug;47(2):222-9.

PMID:
9694671
22.

PspA and PspC: their potential for use as pneumococcal vaccines.

Briles DE, Hollingshead SK, Swiatlo E, Brooks-Walter A, Szalai A, Virolainen A, McDaniel LS, Benton KA, White P, Prellner K, Hermansson A, Aerts PC, Van Dijk H, Crain MJ.

Microb Drug Resist. 1997 Winter;3(4):401-8. Review. No abstract available.

PMID:
9442494
23.

Risk factors for nasopharyngeal carriage of resistant Streptococcus pneumoniae and detection of a multiply resistant clone among children living in the Yukon-Kuskokwim Delta region of Alaska.

Ussery XT, Gessner BD, Lipman H, Elliott JA, Crain MJ, Tien PC, Parkinson AJ, Davidson M, Facklam RR, Breiman RF.

Pediatr Infect Dis J. 1996 Nov;15(11):986-92.

PMID:
8933546
24.

Evidence for the simultaneous expression of two PspAs by a clone of capsular serotype 6B Streptococcus pneumoniae.

Crain MJ, Turner JS, Robinson DA, Coffey TJ, Brooks-Walter A, McDaniel LS, Briles DE.

Microb Pathog. 1996 Oct;21(4):265-75.

PMID:
8905615
25.

DNA polymorphisms and variant penicillin-binding proteins as evidence that relatively penicillin-resistant pneumococci in western Canada are clonally related.

Swiatlo E, Crain MJ, McDaniel LS, Brooks-Walter A, Coffey TJ, Spratt BG, Morrison DA, Briles DE.

J Infect Dis. 1996 Oct;174(4):884-8.

PMID:
8843237
26.

Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus.

Boucher FD, Modlin JF, Weller S, Ruff A, Mirochnick M, Pelton S, Wilfert C, McKinney R Jr, Crain MJ, Elkins MM, et al.

J Pediatr. 1993 Jan;122(1):137-44.

PMID:
8419601
27.

Molecular localization of variable and conserved regions of pspA and identification of additional pspA homologous sequences in Streptococcus pneumoniae.

McDaniel LS, Sheffield JS, Swiatlo E, Yother J, Crain MJ, Briles DE.

Microb Pathog. 1992 Oct;13(4):261-9.

PMID:
1363703
28.

Evidence for a clonal origin of relative penicillin resistance among type 9L pneumococci in northwestern Canada.

Waltman WD 2nd, Talkington DF, Lipinski AE, Crain MJ, Dixon JM, Briles DE.

J Infect Dis. 1992 Apr;165(4):671-5.

PMID:
1552195
29.

Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae.

Briles DE, Crain MJ, Gray BM, Forman C, Yother J.

Infect Immun. 1992 Jan;60(1):111-6.

30.

High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.

Saag MS, Crain MJ, Decker WD, Campbell-Hill S, Robinson S, Brown WE, Leuther M, Whitley RJ, Hahn BH, Shaw GM.

J Infect Dis. 1991 Jul;164(1):72-80.

PMID:
1676046
31.

Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.

Crain MJ, Waltman WD 2nd, Turner JS, Yother J, Talkington DF, McDaniel LS, Gray BM, Briles DE.

Infect Immun. 1990 Oct;58(10):3293-9.

32.

Epstein-Barr virus preferentially induces proliferation of primed B cells.

Crain MJ, Sanders SK, Butler JL, Cooper MD.

J Immunol. 1989 Sep 1;143(5):1543-8.

PMID:
2547870
33.

Naturally occurring antibodies to phosphocholine as a potential index of antibody responsiveness to polysaccharides.

Briles DE, Scott G, Gray B, Crain MJ, Blaese M, Nahm M, Scott V, Haber P.

J Infect Dis. 1987 Jun;155(6):1307-14.

PMID:
3572041
34.

Patients with Wiskott-Aldrich syndrome have normal IgG2 levels.

Nahm MH, Blaese RM, Crain MJ, Briles DE.

J Immunol. 1986 Dec 1;137(11):3484-7.

PMID:
3782789
35.
36.

Evaluation of lymphocyte differentiation in primary and secondary immunodeficiency diseases.

Tedder TF, Crain MJ, Kubagawa H, Clement LT, Cooper MD.

J Immunol. 1985 Sep;135(3):1786-91.

PMID:
3160779
37.

Physician assistant: a profile of the profession, 1976.

Light JA, Crain MJ, Fisher DW.

PA J. 1977 Fall;7(3):109-23. No abstract available.

PMID:
10314405

Supplemental Content

Loading ...
Support Center